# A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

> **NCT00501267** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** solabegron and oxybutynin

## Key facts

- **NCT ID:** NCT00501267
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501267, "A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00501267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*